[Hiring] Associate Director, Cell Therapy Non-Personal Promotions @Iovance Biotherapeutics

Role Description

The Associate Director, Cell Therapy Non-Personal Promotions will oversee the management and execution of non-personal promotion (NPP) content for both HCP and patient audiences, ensuring cohesive, high-impact engagement across digital channels. This role also offers the opportunity to build and scale best-in-class digital engagement models in close partnership with Brand HCP and Patient business leads, Insights, and agency teams.

• Support non-personal promotion (NPP) omnichannel execution while identifying and designing integrated engagement opportunities aligned to customer insights, audience segmentation, and brand objectives.
• Partner with both HCP and Patient Marketing business leads to understand engagement strategy, objectives, market research, and key priorities.
• Lead HCP NPP planning and execution to support education, engagement, and message reinforcement across relevant digital and media channels.
• Lead patient and caregiver NPP planning and execution to support disease-state education, branded engagement, and appropriate journey-based communications.
• Translate brand objectives, customer insights, audience segmentation, and market research into engaging and effective non-personal promotional campaigns that meet audience needs and preferences while ensuring consistent messaging across multiple digital channels.
• Partner with and manage day-to-day activities with the media agency.
• Partner with business leads and BAI to analyze NPP campaign performance, define and track KPIs, develop dashboards, identify actionable insights, and optimize future initiatives through ongoing test-and-learn planning.
• Offer targeted digital solutions and strategies to enhance NPP, brand, and disease-state education strategies and reach the right HCPs, patients, and caregivers.
• Identify and evaluate new marketing technology platforms that support future readiness and engagement models such as AI and emerging digital solutions.
• Serve as the NPP content owner in the promotional review committee process, partnering with the weekly review team to manage assets from creation through execution across NPP channels.
• Collaborate closely with cross-functional stakeholders (Medical Affairs, Market Access, Commercial, Legal) to ensure alignment of NPP brand strategy and execution is effective and compliant.
• Manage NPP omnichannel tactical execution budget effectively to ensure efficient resource allocation.

Qualifications

• 5+ years of relevant marketing experience.
• A bachelor’s degree in marketing or related fields is required.
• Oncology and/or cellular therapy marketing experience preferred.
• Experience building, managing, measuring, and optimizing non-personal promotional campaigns.
• Experience in metastatic melanoma is highly preferred.
• Proven ability to work with cross-functional teams or work groups in a small company environment.
• Strong strategic thinker with ability to formulate, develop and execute strategy.
• Intellectually curious with the ability to process a great deal of information in a fast-paced evolving environment.
• Excellent interpersonal skills with ability to lead, interact with, focus, resolve conflict and drive consensus among individuals from a variety of cultures and disciplines.
• Strong team player and motivated individual contributor.
• Results oriented with sense of urgency.
• Excellent communications skills with an ability to efficiently and productively communicate both orally and in writing.

Requirements

• Sit for extended period of time in front of computer (2-4 hours).
• Travel up to 30% (domestic).

Pay Transparency

The annual base salary we reasonably expect to pay is listed. Individual pay decisions depend on various factors, such as primary work location, complexity and responsibility of the role, job duties/requirements, and relevant education, experience and skills.

$200,000 — $215,000 USD

Company Description

Iovance Biotherapeutics, Inc. is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Iovance operates as an end-to-end cell therapy company, anchored by fully owned, centralized U.S.-based manufacturing that is scaled to serve thousands of cancer patients worldwide each year.